Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Mondello, Stefania ^a   Kobeissy, Firas ^b   Vestri, Annarita ^c   Hayes, Ronald L ^d   Kochanek, Patrick M ^e   Berger, Rachel P ^f  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Banyan Biomarkers Inc   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; MBP PROTEIN, HUMAN; MYELIN BASIC PROTEIN; PROTEIN S100B; S100B PROTEIN, HUMAN; UBIQUITIN THIOLESTERASE; UCHL1 PROTEIN, HUMAN;

BLOOD; CASE CONTROL STUDY; CHILD; FEMALE; HUMAN; MALE; PATHOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; X-RAY COMPUTED TOMOGRAPHY;

BIOMARKERS; BRAIN INJURIES, TRAUMATIC; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MYELIN BASIC PROTEIN; PROSPECTIVE STUDIES; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UBIQUITIN THIOLESTERASE;

EID: 84975452954     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28203     Document Type: Article

References (48)

1. Geneva, World Health Organization. World report on child injury prevention. http://whqlibdoc.who.int/publications/2008/9789241563574-eng.pdf, (2008) (Date of access: 21/01/2015).
2. Field, M., Collins, M. W., Lovell, M. R., Maroon, J. Does age play a role in recovery from sports-related concussion? A comparison of high school and collegiate athletes. J Pediatr 142, 546-553 (2003).
3. Giza, C. C., Griesbach, G. S., Hovda, D. A. Experience-dependent behavioral plasticity is disturbed following traumatic injury to the immature brain. Behav Brain Res 157, 11-22 (2005).
4. Anderson, V., Catroppa, C., Morse, S., Haritou, F., Rosenfeld, J. Recovery of intellectual ability following traumatic brain injury in childhood: impact of injury severity and age at injury. Pediatr Neurosurg 32, 282-290 (2000).
5. Laribi, S. et al. S100B blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study. Clin Chem Lab Med: CCLM/FESCC 52, 527-536 (2014).
6. Berger, R. P., Pierce, M. C., Wisniewski, S. R., Adelson, P. D., Kochanek, P. M. Serum S100B concentrations are increased after closed head injury in children: A preliminary study. J Neurotrauma 19, 1405-1409 (2002).
7. Brouns, R. et al. The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke. Neurochem Res 35, 1315-1322 (2010).
8. Brouns, R. et al. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. Stroke 41, 863-868 (2010).
9. Portela, L. V. et al. The serum S100B concentration is age dependent. Clin Chem 48, 950-952 (2002).
10. Bechtel, K., Frasure, S., Marshall, C., Dziura, J., Simpson, C. Relationship of serum S100B levels and intracranial injury in children with closed head trauma. Pediatrics 124, e697-704 (2009).
11. Berger, R. P., Adelson, P. D., Richichi, R., Kochanek, P. M. Serum biomarkers after traumatic and hypoxemic brain injuries: insight into the biochemical response of the pediatric brain to inflicted brain injury. Dev Neurosci 28, 327-335 (2006).
12. Brophy, G. M. et al. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J Neurotrauma 28, 861-870 (2011).
13. Mondello, S. et al. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit Care 15, R156 (2011).
14. Mondello, S. et al. Clinical Utility of Serum Levels of Ubiquitin C-Terminal Hydrolase as a Biomarker for Severe Traumatic Brain Injury. Neurosurgery 70, 666-675 (2012).
15. Berger, R. P., Hayes, R. L., Richichi, R., Beers, S. R., Wang, K. K. W. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and alpha II-Spectrin Breakdown Product 145 kDa Correlate with Outcome after Pediatric TBI. J Neurotrauma 29 (2012).
16. Mondello, S. et al. Blood-based diagnostics of traumatic brain injuries. Expert Rev Mol Diagn 11, 65-78 (2011).
17. Papa, L. et al. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med 59, 471-483 (2012).
18. Vos, P. E. et al. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 75, 1786-1793 (2010).
19. Mannix, R., Eisenberg, M., Berry, M., Meehan, W. P., 3rd & Hayes, R. L. Serum biomarkers predict acute symptom burden in children after concussion: a preliminary study. J Neurotrauma 31, 1072-1075 (2014).
20. Fraser, D. D. et al. Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum. Pediatr Crit Care Med 12, 319-324 (2011).
21. Berger, R. P. et al. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J Neurosurg 103, 61-68 (2005).
22. Berger, R. P. et al. Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: A possible screening tool. Pediatrics 117, 325-332 (2006).
23. Yuh, E. L. et al. Magnetic resonance imaging improves 3-month outcome prediction in mild traumatic brain injury. Ann Neurol 73, 224-235 (2013).
24. Yuh, E. L. et al. Diffusion tensor imaging for outcome prediction in mild traumatic brain injury: a TRACK-TBI study. J Neurotrauma 31, 1457-1477 (2014).
25. Huang, Y. L. et al. Susceptibility-weighted MRI in mild traumatic brain injury. Neurology 84, 580-585 (2015).
26. Ryan, J. B. et al. Familial dysalbuminaemic hyperthyroxinaemia: a rapid and novel mass spectrometry approach to diagnosis. Ann Clin Biochem (2015).
27. Roozenbeek, B., Maas, A. I., Menon, D. K. Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol 9, 231-236 (2013).
28. Metting, Z., Wilczak, N., Rodiger, L. A., Schaaf, J. M., van der Naalt, J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 78, 1428-1433 (2012).
29. Kou, Z. et al. Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot study. Plos One 8, e80296 (2013).
30. Mondello, S. et al. Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure. BMC Neurol 12, 85 (2012).
31. Merlo Pich, E. et al. Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology? Alzheimers Res Ther 6, 51 (2014).
32. Mac Donald, C. L. et al. Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury. Exp Neurol 205, 116-131 (2007).
33. Raimondi, A. J., Hirschauer, J. Head injury in the infant and toddler. Coma scoring and outcome scale. Childs brain 11, 12-35 (1984).
34. Godoy, D. A., Rubiano, A., Rabinstein, A. A., Bullock, R., Sahuquillo, J. Moderate Traumatic Brain Injury: The Grey Zone of Neurotrauma. Neurocrit Care (2016).
35. Calcagnile, O., Unden, L., Unden, J. Clinical validation of S100B use in management of mild head injury. BMC Emerg Med 12, 13 (2012).
36. Diaz-Arrastia, R. et al. Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup. J Neurotrauma 31, 135-158 (2014).
37. Mondello, S. et al. CSF and plasma amyloid-beta temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury. Sci Rep 4, 6446 (2014).
38. Zetterberg, H. et al. Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid beta levels in humans. PLoS One 6, e28263 (2011).
39. Ferguson, I. et al. Neuronal Biomarkers May Require Age-Adjusted Norms. Ann Emerg Med 58, S213-S213 (2011).
40. Saunders, N. R., Liddelow, S. A., Dziegielewska, K. M. Barrier mechanisms in the developing brain. Front Pharmacol 3, 46 (2012).
41. Sakurai, M. et al. Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J Cell Sci 119, 162-171 (2006).
42. Lankes, U., Brennan, S. O., Walmsley, T. A., George, P. M. Relative quantification of albumin and fibrinogen modifications by liquid chromatography tandem mass spectrometry in the diagnosis and monitoring of acute pancreatitis. J Chromatogr B Analyt Technol Biomed Life Sci 988, 121-126 (2015).
43. Gazzolo, D. et al. Pediatric concentrations of S100B protein in blood: Age-and sex-related changes. Clin Chem 49, 967-970 (2003).
44. Savola, O. et al. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 56, 1229-1234 (2004).
45. Pelinka, L. E. et al. Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock 21, 72-76 (2004).
46. De Witte, L. et al. Cognitive, affective and behavioural disturbances following vascular thalamic lesions: a review. Cortex 47, 273-319 (2011).
47. Ren, C. et al. Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients. Sci Rep 6, 24588 (2016).
48. Thaler, H. W. et al. Evaluation of S100B in the diagnosis of suspected intracranial hemorrhage after minor head injury in patients who are receiving platelet aggregation inhibitors and in patients 65 years of age and older. J Neurosurg 123, 1202-8 (2015).